ArticlePlant biotechnology journal2025
Aquilaria sinensis MYB-Like Transcription Factor AsMYB1 Promotes 2-(2-Phenylethyl)Chromone Biosynthesis Through Interacting With 14-3-3 Family Protein AsGRF1.
Article in Plant biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
2-(2-Phenylethyl)chromones (PECs) are the primary constituents of agarwood, a valuable aromatic resin widely used in traditional oriental medicine and incense production, exhibiting diverse pharmacological activities. While we have previously reported a polyketide synthase (AsPECPS) playing a crucial role in the biosynthesis of PECs in agarwood, the intrinsic regulatory mechanisms underlying PEC biosynthesis remain largely elusive. Here, we successfully characterised a new 1R-subtype myeloblastosis (MYB) transcription factor (AsMYB1) from Aquilaria sinensis whose expression is significantly induced under salt treatment. Further overexpression, RNA interference (RNAi) and gene-editing experiments confirmed the positive regulatory role of AsMYB1 in PEC biosynthesis. AsMYB1 specifically bound to cis-elements in the promoter of AsPECPS to enhance its transcription, thereby promoting PEC accumulation under salt stress. A 14-3-3 family protein designated AsGRF1 was characterised to interact with AsMYB1 both in vivo and in vitro, and knockdown or knockout of AsGRF1 led to a dramatic reduction in AsPECPS expression and PECs' accumulation. Furthermore, AsGRF1 may positively facilitate AsMYB1-mediated activation of PEC production under salt stress by elevating AsPECPS expression through increasing the transcriptional activity, nuclear localisation and stability of AsMYB1. Our findings suggest that the AsGRF1-AsMYB1-AsPECPS module synergistically facilitates salt-induced PEC metabolism, inspiring potential biotechnological strategies to improve agarwood quality through metabolic engineering.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.